+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemato Oncology Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • Report
  • 100 Pages
  • October 2019
  • Region: Global
  • Infinium Global Research
  • ID: 4857548
The report on the global hemato oncology testing market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global hemato oncology testing market to grow with a CAGR of 14.5% over the forecast period from 2019-2025. The study on hemato oncology testing market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on hemato oncology testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hemato oncology testing market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hemato oncology testing market over the period of 2017 to 2025. Further, the Growth Matrix given in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings:

1. Drivers
  • Growing awareness about personalized medicines
  • Increasing cases of hematologic cancer
  • Surge in the number of collaborations to develop new assays

2. Restraints
  • Uncertain reimbursement scenario in various regions

3. Opportunities
  • Research and development in hemato oncology testing

Research Methodology

A. Primary Research

Primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

1. Key Opinion Leaders associated with the publisher
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Primary research respondents typically include:

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B. Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global hemato oncology testing market is segmented on the basis of products & services, cancer, technology, and end-user.

The Global Hemato Oncology Testing Market by Products & Services
  • Assay Kits
  • Services

The Global Hemato Oncology Testing Market by Cancer
  • Leukemia
  • Non-hodgkin Lymphoma
  • Other Cancers

The Global Hemato Oncology Testing Market by Technology
  • PCR
  • NGS
  • IHC
  • Other Technologies

The Global Hemato Oncology Testing Market by End-user
  • Clinical Laboratories
  • Hospitals
  • Other End-users

Company Profiles

The companies covered in the report include
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffman-La Roche AG
  • QIAGEN NV
  • Arup Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • ArcherDx, Inc.
  • Asuragen, Inc.
  • Invivoscribe Technologies, Inc.
  • Other companies

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the hemato oncology testing market.
2. Complete coverage of all the segments in the hemato oncology testing market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global hemato oncology testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. The Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Hemato Oncology Testing Market Highlights
2.2. Hemato Oncology Testing Market Projection
2.3. Hemato Oncology Testing Market Regional Highlights
3. Global Hemato Oncology Testing Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Products & Services
3.4.2. Growth Matrix Analysis by Cancer
3.4.3. Growth Matrix Analysis by Technology
3.4.4. Growth Matrix Analysis by End-user
3.4.5. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Hemato Oncology Testing Market
4. Hemato Oncology Testing Market Macro Indicator Analysis
5. Global Hemato Oncology Testing Market by Products & Services
5.1. Assay Kits
5.2. Services
6. Global Hemato Oncology Testing Market by Cancer
6.1. Leukemia
6.2. Non-hodgkin Lymphoma
6.3. Other Cancers
7. Global Hemato Oncology Testing Market by Technology
7.1. PCR
7.2. NGS
7.3. IHC
7.4. Other Technologies
8. Global Hemato Oncology Testing Market by End-user
8.1. Clinical Laboratories
8.2. Hospitals
8.3. Other End-users
9. Global Hemato Oncology Testing Market by Region 2019-2025
9.1. North America
9.1.1. North America Hemato Oncology Testing Market by Products & Services
9.1.2. North America Hemato Oncology Testing Market by Cancer
9.1.3. North America Hemato Oncology Testing Market by Technology
9.1.4. North America Hemato Oncology Testing Market by End-user
9.1.5. North America Hemato Oncology Testing Market by Country
9.2. Europe
9.2.1. Europe Hemato Oncology Testing Market by Products & Services
9.2.2. Europe Hemato Oncology Testing Market by Cancer
9.2.3. Europe Hemato Oncology Testing Market by Technology
9.2.4. Europe Hemato Oncology Testing Market by End-user
9.2.5. Europe Hemato Oncology Testing Market by Country
9.3. Asia-Pacific
9.3.1. Asia-Pacific Hemato Oncology Testing Market by Products & Services
9.3.2. Asia-Pacific Hemato Oncology Testing Market by Cancer
9.3.3. Asia-Pacific Hemato Oncology Testing Market by Technology
9.3.4. Asia-Pacific Hemato Oncology Testing Market by End-user
9.3.5. Asia-Pacific Hemato Oncology Testing Market by Country
9.4. RoW
9.4.1. RoW Hemato Oncology Testing Market by Products & Services
9.4.2. RoW Hemato Oncology Testing Market by Cancer
9.4.3. RoW Hemato Oncology Testing Market by Technology
9.4.4. RoW Hemato Oncology Testing Market by End-user
9.4.5. RoW Hemato Oncology Testing Market by Sub-region
10. Company Profiles and Competitive Landscape
10.1. Competitive Landscape in the Global Hemato Oncology Testing Market
10.2. Companies Profiled
10.2.1. Abbott Laboratories
10.2.2. Thermo Fisher Scientific, Inc.
10.2.3. Illumina, Inc.
10.2.4. F. Hoffman-La Roche AG
10.2.5. QIAGEN NV
10.2.6. Arup Laboratories Inc.
10.2.7. Bio-Rad Laboratories, Inc.
10.2.8. ArcherDx, Inc.
10.2.9. Asuragen, Inc.
10.2.10. Invivoscribe Technologies, Inc.
10.2.11. Other Companies
11. Appendix
11.1. Primary Research Findings and Questionnaire

Companies Mentioned

  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Illumi, Inc.
  • F. Hoffman-La Roche AG
  • QIAGEN NV
  • Arup Laboratories Inc.
  • Bio-Rad Laboratories, Inc.
  • ArcherDx, Inc.
  • Asuragen, Inc.
  • Invivoscribe Technologies, Inc.
  • Other companies